BOZEN, Sud-Tirol, Italy, March 29, 2010 Health Roboticstoday announced the successful global launch of the Beta Installationkick-off for its 3 latest i.v.SOFT Workflow Engine software automationmodules [Assist, Label+ and Profile] in Nice [France], the 2010 venue for theEuropean Association of Hospital Pharmacists. i.v.SOFT helps PharmacyTechnicians, I.V. Room Supervisors, and Pharmacy Directors to compound andmanage the safe and efficient manual production of IV Admixtures according tohospital-defined sterile compounding guidelines, and to help bring thepharmacies into compliance with USP 797 regulations in the United States andGMP guidelines elsewhere.
"7 of the world's top-rated hospitals recently signed contracts for Betainstallations of i.v.SOFT Assist, Label+, and Profile to take place over thenext 6 months at Brigham & Women's Hospital in Boston, The Cleveland ClinicFoundation, Imperial College Healthcare NHS Trust [London], JohannesGutenberg University of Mainz Hospital [Germany], Princess Margaret Hospital[Toronto], The University of Chicago Medical Center, and The University ofTexas M.D. Anderson Cancer Center in Houston, with 3 additional leadingmedical centers to be announced shortly. These 3 new software modules will beintegrated with the rest of the i.v.SOFT's solutions that were released tothe market in prior years [Cube, Dashboard, Worklist, Integration, Infusion].A final software module (i.v.SOFT Track] will remain in developmentthroughout 2010", stated Werner Rainer, CEO of Health Robotics.
i.v.SOFT Assist constitutes an ideal complement to CytoCare andi.v.STATION both as a means to back-up robotic devices and to direct excessIV Admixture production demand and non-standard IV consumables (i.e. cassettepumps, ampoules, glass bottles, IV doses requiring the use of CSTDs, etc.)towards Laminar Airflow Hoods equipped with Health Robotics' life-criticali.v.SOFT software . Additionally, i.v.SOFT Assist provides the means toensure that all IVs [not just those IVs produced by CytoCare and i.v.STATION]are: i) free of life-threatening drug-exchange errors; ii) supported bytele-pharmacy functionality for pharmacist's secure review and approval; iii)compounded by pharmacy technicians with a minimum 95% accuracy; and iv)manufactured with no or minimal waste through its unique proactive alerts totechnicians during the Admixture preparation (as opposed to competitor'sproducts reliance on retrospective review which causes costly "re-makes").
i.v.SOFT Label+, when combined with i.v.STATION or CytoCare representsunlimited flexibility in IV labels, including large multi-page administrationinstructions for example in chemotherapy or full-color labels for anesthesia.As a result of Anesthesia Therapy suffering from serious patient safetychallenges., numerous regulatory bodies offer guidelines for medicationlabeling. Label+ aids in filling this need by helping ensure compliance withthese guidelines, while improving workflow, efficiency, and accuracy; itproduces full-color labels that comply with the 2010 National Safety PatientGoals of The Joint Commission (TJC) and American Society of Anesthesiologists(ASA) Guidelines.
Exactly like its companion i.v.STATION Profile, i.v.SOFT Profile providesIV Room Supervisors with the ability to remotely observe and manage completeaudit trails of the IV Admixture process without needing to "gown-up" andenter the IV Room. These Tele-Dispensing features provide the added benefitto supervise IV Admixture compounding tasks from locations outside thePharmacy [and within and outside the Health-System] via secure intranetaccess, therefore enabling optimization of scarce pharmacy resources.
About Health Robotics:
Health Robotics is the undisputed global leading supplier oflife-critical intra-venous medication robots, providing healthcare facilitiesin 5 continents with robotics technology and software automation solutions.Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM)[non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding,powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteralnutrition] have and will greatly contribute to ease hospitals' growingpressures to improve patient safety, increase throughput and contain costs.Through the effective and efficient production of sterile, accurate,tamper-evident and ready-to-administer IVs, Health Robotics' solutions helphospitals eliminate life-threatening drug-exchange errors, decrease othertherapy oversights and sterility risks, work more efficiently, reduce wasteand controlled substances' diversion, and diminish the gap between risingpatient volume/acuity and scarce nursing and pharmacy staff. For moreinformation, please visit http://www.health-robotics.comFor additional information, please contact: Health Robotics S.r.l. Gaspar G. DeViedma, Executive V.P., General Counsel, and Member of the Board of Directors Italy: +39-346-963-4934 USA: +1-609-980-7976 Canada: +1-289-470-1456 Malaysia: +60-321-848-223 email@example.com
SOURCE Health Robotics